(19)
(11)
EP 4 770 640 A1
(12)
(43)
Date of publication:
08.07.2026
Bulletin 2026/28
(21)
Application number:
24768004.4
(22)
Date of filing:
30.08.2024
(51)
International Patent Classification (IPC):
A61K
31/40
(2006.01)
A61P
25/26
(2006.01)
A61P
25/00
(2006.01)
(52)
Cooperative Patent Classification (CPC):
A61K
31/40
;
A61P
25/26
;
A61P
25/00
(86)
International application number:
PCT/EP2024/074250
(87)
International publication number:
WO 2025/046050
(
06.03.2025
Gazette 2025/10)
(84)
Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN
(30)
Priority:
30.08.2023
US 202363579588 P
(71)
Applicant:
Noema Pharma AG
4051 Basel (CH)
(72)
Inventor:
GARIBALDI, George
4052 Basel (CH)
(74)
Representative:
Icosa
83 avenue Denfert-Rochereau
75014 Paris
75014 Paris (FR)
(54)
METHODS OF TREATING A SLEEP DISORDER USING A TRIPLE REUPTAKE INHIBITOR